Aqemia
<cite index="1-6,1-7">Aqemia combines generative AI with deep physics simulations to revolutionize drug discovery at the molecular level. Founded in 2019, it has raised over $100 million and, in 2025, expanded its operations to London as it moves closer to launching clinical trials for its AI-discovered drug candidates.</cite> <cite index="1-5">Reduces the energy consumption of AI training by up to 80%, enabling scalable and eco-friendly AI deployments.</cite>
<cite index="1-9">A $38 million funding round in 2024 and a grant from the France 2030 plan.</cite> Moving toward clinical trials with AI-discovered drug candidates demonstrates material product progress.
No products catalogued yet. Press Refresh above to ask the research agent.
No people linked.
No citations stored yet. Run the research agent to attach per-claim sources.